Azabicyclic heterocycles as cannabinoid receptor modulators

Details for Australian Patent Application No. 2004309365 (hide)

Owner Bristol-Myers Squibb Company

Inventors Sun, Chongqing; Ellsworth, Bruce A.; Wang, Ying; Mikkilineni, Amarendra B.; Wu, Ximao; Murugesan, Natesan; Ewing, William R.; Gu, Zhengxiang; Johnson, Stephen R.; Wu, Gang; Yu, Guixue; Sher, Philip M.; Sitkoff, Doree; Pendri, Annapurna; Huang, Yanting; Gerritz, Samuel

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004309365

PCT Pub. Number WO2005/063761

Priority 60/531,451 19.12.03 US; 11/016,135 17.12.04 US

Filing date 17 December 2004

Wipo publication date 14 July 2005

International Classifications

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/063761 Priority application(s): WO2005/063761

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004309366-Playing field obstacle device

2004309361-Polymer blends with improved rheology and improved unnotched impact strength